
    
      The registry is a prospective, multicenter, single arm post-market real-world registry in the
      U.S. assessing the clinical use, safety and outcomes of the Lutonix 035 DCB Catheter in the
      Superficial Femoral Artery (SFA) and Popliteal Arteries (PA). Registry subjects will be
      followed for up to three year's post-index procedure.
    
  